Results 191 to 200 of about 12,810,150 (402)
Longitudinal Study of Salivary Biomarkers in the Definition of Clinico‐Molecular Progression of Parkinson's Disease
Annals of Clinical and Translational Neurology, EarlyView.Longitudinal changes in salivary biomarkers in Parkinson’s disease (PD) from early (T0) to 4‐year follow‐up (T1), quantified by ELISA: oligomeric and total α‐synuclein, total and phosphorylated tau, MAP1LC3B (autophagy), and TNFa (inflammation). Blue arrows indicate direction of change at T1 vs T0 (up = increase; down = decrease).Maria Ilenia De Bartolo, Daniele Belvisi, Matteo Costanzo, Claudia Caturano, Francesco Emanuele Bellomi, Carolina Cutrona, Flavia Aiello, Giorgio Leodori, Massimo Marano, Romina Mancinelli, Antonella Conte, Giovanni Fabbrini, Alfredo Berardelli, Giorgio Vivacqua +13 morewiley +1 more sourceCharacteristics of Cerebral Palsy in the Midwestern US
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
Cerebral palsy (CP) is the most common lifelong motor disability worldwide. Yet, data is limited on how CP manifests in the US. Our objective was to characterize and determine factors affecting functional outcomes in a large population of young people with CP in the Midwestern US.Susie Kim, Kelsey Steffen, Lauren Gottschalk‐Henneberry, Jennifer Miros, Amy Robichaux‐Viehoever, Karen Taca, Bhooma R. Aravamuthan +6 morewiley +1 more sourceSmartphone-based multispectral imaging: system development and potential for mobile skin diagnosis
, 2016 Sewoong Kim, Dongrae Cho, Jihun Kim, Manjae Kim, Sangyeon Youn, Jae Eun Jang, Minkyu Je, Dong Hun Lee, Boreom Lee, Daniel L. Farkas, Jae Youn Hwang +10 moreopenalex +1 more sourceTracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.David Ledingham, Sahana Sathyanarayana, Charlotte B. Stewart, Robyn Iredale, Victoria Foster, Debra Galley, Mark Baker, Nicola Pavese +7 morewiley +1 more sourceA multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis
, 2023 Lynn Daboul, Carly M. O’Donnell, Moein Amin, Paulo Rodrigues, J. Andrew Derbyshire, Christina Azevedo, Amit Bar‐Or, Eduardo Caverzasi, Peter A. Calabresi, Bruce Cree, Léorah Freeman, Roland G. Henry, Erin E. Longbrake, Jiwon Oh, Nico Papinutto, Daniel Pelletier, Vesna Prchkovska, Praneeta Raza, Marc Ramos, Rohini Samudralwar, Matthew K. Schindler, Elias S. Sotirchos, Nancy L. Sicotte, Andrew Solomon, Russell T. Shinohara, Daniel S. Reich, Pascal Sati, Daniel Ontaneda +27 moreopenalex +2 more sourcesGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
American Journal of Respiratory and Critical Care Medicine, 2007 K. Rabe, S. Hurd, A. Anzueto, P. Barnes, Sonia Buist, P. Calverley, Yoshinosuke Fukuchi, C. Jenkins, R. Rodríguez-Roisín, C. van Weel, Jan Zieliński +10 moresemanticscholar +1 more sourceChange in Cognition Following Ischaemic Stroke
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective
Cognitive decline can occur following ischaemic stroke. How cognition changes over time and associations with cognitive change are poorly understood. This study aimed to explore these issues over 2 years following ischaemic stroke.Wenci Yan, Terence Quinn, Alex McConnachie, Niall Broomfield, Yun Wong, David Dickie, Kirsten Forbes, Matthew Walters, Jesse Dawson +8 morewiley +1 more source